| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 5 |
| 1 | GEMCITABINE HYDROCHLORIDE | 4 |
| 2 | GEMCITABINE | 2 |
| 3 | PAZOPANIB | 2 |
| 4 | PAZOPANIB HYDROCHLORIDE | 2 |
| 5 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| 6 | CARBOPLATIN | 1 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 1 |
| 8 | IFOSFAMIDE | 1 |
| 9 | IFOSFAMIDE FOR INJECTION | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 1 | PAZOPANIB HYDROCHLORIDE | 2 | 0.0001 |
| 2 | GEMCITABINE HYDROCHLORIDE | 4 | 0.0001 |
| 3 | CISPLATIN | 5 | 0.0001 |
| 4 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 5 | NIRAPARIB | 1 | 0.0000 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
| 7 | VENETOCLAX | 1 | 0.0000 |
| 8 | NIVOLUMAB | 1 | 0.0000 |
| 9 | PACLITAXEL | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 6 |
| 1 | Kinase Inhibitor [EPC] | 2 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 |
| 3 | Alkylating Drug [EPC] | 1 |
| 4 | BCL-2 Inhibitor [EPC] | 1 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 6 | Microtubule Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 6 | 0.0000 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 2 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |